https://www.buenosairesbreakingnews.com/article/893039520-ocular-therapeutix-reports-positive-results-from-landmark-sol-1-phase-3-superiority-trial-in-wet-amd
Ocular Therapeutix™ Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet...
Buenos Aires Breaking News is an online news publication focusing on the Argentina: Following the news from Argentina
superiority trialocularreportspositiveresults
https://keio.elsevierpure.com/en/publications/phase-iii-trial-to-confirm-the-superiority-of-pelvic-and-para-aor/
Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic...
phase iii trialconfirmsuperioritypelvicpara
https://biopharmajournal.com/2021/07/06/citius-pharmaceuticals-inc-nasdaq-ctxr-to-continue-phase-3-pivotal-superiority-trial-after-idmc-did-not-observe-any-safety-concerns/
Citius Pharmaceuticals Inc (NASDAQ: CTXR) To Continue Phase 3 Pivotal Superiority Trial after IDMC...
Jul 6, 2021 - News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or...
to continuesuperiority trialcitiuspharmaceuticalsinc